Fluorescein Injection
Fluorescein Injection - Related Videos
07:35
Lineage Labeling of Zebrafish Cells with Laser Uncagable Fluorescein Dextran
0 Views •
Cited by 8 •
2011
This protocol delineates a way to label and trace the fate of small groups of cells zebrafish embryos using UV-uncaging of caged fluorescein, followed by whole mount immunolabeling to amplify the signal from the uncaged fluorescein.
02:01
Fluorescein Staining in an Autoimmune Dry Eye Rat Model to Examine Corneal Damage
0 Views •
2025
This video demonstrates the staining of the damaged cornea using fluorescein dye to evaluate the extent of autoimmune dry eye disease in a rat model. The green fluorescence spots of the stained collagen fibers indicate corneal epithelial damaged cells.
08:53
Assessment of Neuronal Viability Using Fluorescein Diacetate-Propidium Iodide Double Staining in Cerebellar Granule Neuron Culture
0 Views •
Cited by 29 •
2017
This protocol describes how to accurately measure neuronal viability using Fluorescein diacetate (FDA) and Propidium Iodide (PI) double staining in cultured cerebellar granule neurons, a primary neuronal culture used as an in vitro model in neuroscience and neuropharmacology research.
11:54
Identification and Isolation of Slow-Dividing Cells in Human Glioblastoma Using Carboxy Fluorescein Succinimidyl Ester (CFSE)
0 Views •
Cited by 18 •
2012
This video protocol demonstrates the application of the fluorescent dye carboxyfluorescein succinimidyl ester (CFSE) for the identification and separation of different sub-populations of cells in human glioblastoma based on frequency of cell division.
07:13
An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
0 Views •
Cited by 19 •
2016
Subretinal injections are the most common technique for delivering large therapeutic agents such as proteins and viral vectors to photoreceptors and the retinal pigment epithelium. An alternative method in mice that successfully targets the subretinal space with minimal collateral damage and fast recovery times is described here.
FAQs
Fluorescein's diagnostic value comes from its light-responsive signal. After reaching ocular vessels through the bloodstream, the dye emits yellow-green fluorescence under appropriate illumination. This signal creates an image of dye-containing blood within the retinal and choroidal circulation, allowing clinicians to evaluate vascular filling and identify abnormalities that may not be apparent from circulation alone.
Sequential imaging records how fluorescence changes as the dye moves through retinal and choroidal vessels. Early and later images can show the timing and distribution of vascular filling, while abnormal fluorescence may reveal leakage. This time-resolved view helps clinicians assess circulation changes more precisely than a single image and supports evaluation of ocular vascular abnormalities.
A blockage is associated with abnormal or absent vascular filling in the affected circulation, whereas leakage reflects dye extending beyond the expected vessel pattern. These findings represent different types of vascular abnormality and provide distinct clues during image interpretation. Recognizing the difference helps characterize the circulation change associated with an eye disorder and supports clinical assessment.
Fluorescein angiography can show blood flow in both retinal and choroidal vessels, so assessment is not limited to one vascular region. Examining these areas helps indicate where an abnormality is located and whether the observed change involves retinal circulation, choroidal circulation, or both. This broader view supports evaluation of vascular disorders that affect vision.
During the procedure, fluorescein is administered intravenously and allowed to circulate through the ocular vasculature. Appropriate illumination then reveals the dye, and sequential images document vascular filling and possible leakage. The resulting image series provides a record of dye passage through retinal and choroidal vessels that can be reviewed for clinically relevant circulation abnormalities.
Its clinical contribution extends beyond detecting an abnormality. Findings from the resulting angiographic images can support diagnosis of eye disease, help guide treatment planning, and provide information for monitoring vascular disorders affecting vision. Because the images demonstrate circulation and leakage, they give clinicians a focused way to assess the status of ocular vascular changes over time.